Douglas Janzen

Douglas Janzen

Vorstandsvorsitzender bei AEQUUS PHARMACEUTICALS INC.

Vermögen: 12 554 $ am 30.06.2026

58 Jahre
Health Technology
Finance
Commercial Services

Profil

Douglas Glen Janzen is the founder of Aequus Pharmaceuticals, Inc., founded in 2013, serving as Chairman, President & Chief Executive Officer.
Mr. Janzen is the founder of Northview LifeSciences, founded in 2014.
Mr. Janzen is the founder of Northview Ventures & Associates General Partnership, founded in 2014, serving as Managing Director.
Current jobs include Chairman at Lexington Biosciences Holdings Corp.
since 2017, Director & Managing Director at LifeSciences British Columbia since 2010, Director at Synaptive Technologies Ltd., Director at Transdermal Research Pharm Laboratories LLC since 2013, and Director at Alabaster Technologies, Inc. Former jobs include President, Chief Executive Officer & Director at Correvio Pharma Corp.
from 2010 to 2012, Chairman at AbCellera Biologics, Inc., Chairman at Lexington Biosciences, Inc. from 2016 to 2021, Chairman at Perimeter Medical Imaging, Inc., Director at Medical Ventures Corp., Director at Teal Valley Health, Inc., Director at Aptamera, Inc., Director at Synaptive Medical, Inc., Director at BIOTECanada, Independent Director at iCo Therapeutics, Inc. from 2012 to 2015, Director at Sentinelle Medical ULC, Independent Director at Neovasc, Inc., Director at BioHEP Technologies Ltd., Director at Renaissance BioScience Corp., Director at AmpHP, Inc., Director at Perimeter Medical Imaging AI, Inc., Analyst at Cormark Securities, Inc. in 2002, President & Chief Business Officer at Bradmer Pharmaceuticals, Inc. from 2006 to 2007, and Head of Research at Loewen, Ondaatje, McCutcheon Ltd. in 2001.
Education includes graduate degree from the University of British Columbia and undergraduate degree from the University of Saskatchewan.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
24.09.2025 12’553’800 ( 9.46% ) 12 554 $ 30.06.2026

Aktive Positionen von Douglas Janzen

UnternehmenPositionBeginn
AEQUUS PHARMACEUTICALS INC. Vorstandsvorsitzender 03.01.2013
Gründer 01.04.2014
Alabaster Technologies, Inc.
Direktor/Vorstandsmitglied -
Vorsitzender 23.05.2017
Direktor/Vorstandsmitglied 03.03.2013
Synaptive Technologies Ltd.
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Gründer 01.04.2014

Ehemalige bekannte Positionen von Douglas Janzen

UnternehmenPositionEnde
REGISTERED PLAN PRIVATE INVESTMENTS INC. Vorsitzender 01.12.2021
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Douglas Janzen im Detail an

Ausbildung von Douglas Janzen

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

50

Beziehungen ersten Grades

29

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen29

Finance

Health Technology

Electronic Technology

Technology Services

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

Synaptive Technologies Ltd.

Commercial Services

Health Technology

Alabaster Technologies, Inc.

Health Technology

Health Technology

Health Technology

Finance

  1. Börse
  2. Insiders
  3. Douglas Janzen